1) Cardiac
[英]['kɑ:diæk] [美]['kɑrdɪ'æk]
心脏性
2) cardiotoxicity
心脏毒性
1.
Analysis of Cardiotoxicity of Recombinant Human Endostatin Combined with Chemotherapy;
重组人血管内皮抑素联合化疗心脏毒性的分析
2.
Protective effect of gypenosides on adriamycin induced acute cardiotoxicity in rats;
绞股蓝总皂苷对阿霉素致大鼠急性心脏毒性的保护作用
3.
Signal pathways in doxorubicin-induced cardiotoxicity;
多柔比星致心脏毒性的可能信号途径
3) Cardiotoxity
心脏毒性
1.
Eprirubincin-induced Cardiotoxity in Breast Cancer Patients by Clinical Application of the New Echocardiography Technologies;
超声新技术评价乳腺癌术后患者表阿霉素化疗心脏毒性的价值
2.
Clinical Study of Echocardiography in Assessment of Cardiotoxity in Breast Cancer Patients Treated with Anthracycline;
超声心动图评价蒽环类药对乳腺癌患者心脏毒性的临床研究
3.
Clinical Study of Myocardial Integrated Backscatter Parameters in Assessment of Cardiotoxity of Patients Treated with Anthracycline;
心肌背向散射积分参数评价蒽环类抗肿瘤药心脏毒性的临床研究
4) cardiogenic
[英][,kɑ:diəu'dʒenik] [美][,kɑrdɪo'dʒɛnɪk]
心脏性的
5) cardiac toxicity
心脏毒性
1.
Clinical assessment of cTnI in cardiac toxicity of cyclophosphamide pulse therapy for lupus nephritis
心肌肌钙蛋白Ⅰ对环磷酰胺冲击治疗狼疮肾炎心脏毒性评估的临床意义
2.
Monitoring L-carnitine to reduce cardiac toxicity of anthracyclines
左旋肉碱监测及防治蒽环类抗生素心脏毒性作用
3.
Conclusion:PNS at larger doses (≥150 mg·kg-1) possesses the potential of cardiac toxicity; however the accumulative effect of PNS is not obvious.
结论:大剂量(≥150mg·kg-1)三七总皂苷具有心脏毒性作用,但没有心脏蓄积作用。
6) heart safety
心脏安全性
1.
Clinical evaluation of heart safety for diacetyl hexamethylene diamine(CAHB) in patients with myelodysplastic syndrome(MDS);
二乙酰己二胺(CAHB)治疗骨髓增生异常综合征(MDS)的心脏安全性临床评价
补充资料：连续性与非连续性(见间断性与不间断性)
连续性与非连续性(见间断性与不间断性)
continuity and discontinuity
11an父ux泊g四f“山。麻以角g、.连续性与非连续性(c。nt，n琳t:nuity一)_见间断性与不间断性。and diseo红ti-
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条